Skip to search formSkip to main contentSkip to account menu

CP 154526

Known as: CP 154,526, CP-154,526, CP-154526 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
The brain corticotropin‐releasing hormone (CRH) circuits are activated by stressful stimuli, contributing to behavioral and… 
Highly Cited
2000
Highly Cited
2000
Abstract. Rationale: Intermittent footshock stress reliably reinstates extinguished alcohol-taking behavior in drug-free rats… 
Highly Cited
2000
Highly Cited
2000
Corticotropin-releasing factor 1 (CRF(1)) receptor antagonists may represent a novel group of drugs for the pharmacotherapy of… 
Highly Cited
2000
Highly Cited
2000
BACKGROUND & AIMS Corticotropin-releasing factor (CRF) exerts its action through CRF receptors 1 and 2 (CRF-R1 and CRF-R2). CRF… 
Highly Cited
1999
Highly Cited
1999
The nonpeptide CRH antagonist antalarmin has been shown to block both behavioral and endocrine responses to CRH. However, it's… 
Highly Cited
1998
Highly Cited
1998
Abstract We have found that peptide antagonists of corticotropin-releasing factor (CRF) receptors attenuate reinstatement of… 
Highly Cited
1998
Highly Cited
1998
Abstract The present series of experiments compared the behavioral effects of the novel non-peptide CRF antagonist CP-154,526… 
Highly Cited
1996
Highly Cited
1996
Here we describe the properties of CP-154,526, a potent and selective nonpeptide antagonist of corticotropin (ACTH) releasing… 
Highly Cited
1996